Profile data is unavailable for this security.
About the company
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
- Revenue in USD (TTM)77.06m
- Net income in USD-39.00m
- Incorporated2012
- Employees209.00
- LocationTELA Bio Inc1 Great Valley Parkway, Suite 24MALVERN 19355United StatesUSA
- Phone+1 (484) 320-2930
- Fax+1 (302) 655-5049
- Websitehttps://www.telabio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guided Therapeutics Inc | 178.00k | -2.80m | 26.75m | 4.00 | -- | -- | -- | 150.29 | -0.0386 | -0.0386 | 0.0025 | -0.0675 | 0.1654 | 0.1083 | 44.50 | 44,500.00 | -244.61 | -129.80 | -- | -- | 62.92 | 44.19 | -1,478.65 | -4,184.72 | 0.0334 | -4.13 | -- | -- | -92.86 | -27.93 | 31.07 | -- | -- | -- |
| Baird Medical Investment Holdings Ltd | 31.86m | -3.12m | 28.28m | 143.00 | -- | 0.5745 | -- | 0.8876 | -0.1128 | -0.1128 | 1.22 | 1.34 | 0.4552 | 3.27 | 0.8459 | 222,797.30 | -4.48 | -- | -7.64 | -- | 86.94 | -- | -9.84 | -- | 1.67 | -0.323 | 0.3856 | -- | 17.74 | -- | 18.57 | -- | -- | -- |
| Femasys Inc | 2.06m | -19.80m | 29.72m | 69.00 | -- | 5.28 | -- | 14.42 | -0.7198 | -0.7198 | 0.07 | 0.0963 | 0.1294 | 0.1973 | 4.34 | 29,876.81 | -124.24 | -63.09 | -214.46 | -74.30 | 63.05 | 66.63 | -960.53 | -961.82 | 0.6131 | -9.72 | 0.5982 | -- | 51.97 | 11.89 | -32.07 | -- | 4.01 | -- |
| Myomo Inc | 41.64m | -12.02m | 31.53m | 184.00 | -- | 2.16 | -- | 0.7571 | -0.2885 | -0.2885 | 1.01 | 0.3805 | 1.65 | 3.96 | 9.23 | 226,321.70 | -47.71 | -55.96 | -70.30 | -77.40 | 66.56 | 69.74 | -28.86 | -52.92 | 2.10 | -- | 0.2148 | -- | 69.17 | 53.36 | 24.10 | -- | 92.10 | -- |
| Vaso Corp | 89.11m | 2.59m | 31.67m | 298.00 | 12.26 | 1.12 | 9.56 | 0.3554 | 0.0147 | 0.0147 | 0.5065 | 0.1605 | 1.13 | 34.02 | 10.28 | 299,030.20 | 3.27 | 7.37 | 5.36 | 14.56 | 60.91 | 59.17 | 2.91 | 5.99 | 1.61 | -- | 0.01 | -- | 7.09 | 2.82 | -80.21 | -- | 3.81 | -- |
| EUDA Health Holdings Ltd | 5.16m | -2.06m | 31.76m | 117.00 | 54.37 | -- | -- | 6.15 | 0.0155 | 0.0876 | 0.1483 | -0.0998 | 2.49 | -- | 17.10 | 44,104.96 | -100.77 | -- | -- | -- | 22.39 | -- | -40.53 | -- | 0.2084 | -46.54 | -- | -- | 8.22 | -- | -108.62 | -- | -- | -- |
| Ekso Bionics Holdings Inc | 14.75m | -10.66m | 33.49m | 61.00 | -- | 2.67 | -- | 2.27 | -5.70 | -5.70 | 7.25 | 3.69 | 0.5799 | 1.36 | 2.27 | 241,786.90 | -41.02 | -41.01 | -60.62 | -52.90 | 53.48 | 52.89 | -70.74 | -97.04 | 1.09 | -- | 0.3055 | -- | -1.94 | 5.19 | 25.45 | -- | -9.22 | -- |
| RenovoRx Inc | 928.00k | -11.11m | 34.21m | 10.00 | -- | 4.23 | -- | 36.86 | -0.4375 | -0.4375 | 0.0312 | 0.2204 | 0.0874 | -- | -- | 92,800.00 | -104.58 | -121.57 | -126.33 | -166.50 | 67.78 | -- | -1,196.66 | -90,830.23 | 5.68 | -- | 0.00 | -- | -- | -- | 13.86 | -- | -- | -- |
| TELA Bio Inc | 77.06m | -39.00m | 34.54m | 209.00 | -- | 20.45 | -- | 0.4483 | -0.8863 | -0.8863 | 1.75 | 0.0386 | 1.34 | 2.01 | 6.85 | 368,684.20 | -68.06 | -51.29 | -96.57 | -60.70 | 67.23 | 66.26 | -50.61 | -88.02 | 2.62 | -7.25 | 0.9638 | -- | 18.56 | 35.02 | 18.91 | -- | -18.18 | -- |
| Modular Medical Inc | 0.00 | -24.22m | 35.22m | 54.00 | -- | 3.16 | -- | -- | -0.5081 | -0.5081 | 0.00 | 0.1434 | 0.00 | -- | -- | 0.00 | -222.79 | -171.42 | -294.38 | -207.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.75 | -- | 57.07 | -- |
| Vivos Inc | 48.63k | -3.01m | 35.42m | 10.00 | -- | 16.25 | -- | 728.32 | -0.0068 | -0.0068 | 0.0001 | 0.0048 | 0.0275 | -- | 10.03 | -- | -170.12 | -166.49 | -178.25 | -242.01 | -127.33 | 2.81 | -6,191.01 | -11,105.98 | 19.81 | -- | 0.00 | -- | 43.59 | 24.13 | -0.5424 | -- | -- | -- |
| Precision Optics Corporation Inc | 21.58m | -6.11m | 36.75m | 90.00 | -- | 3.36 | -- | 1.70 | -0.8505 | -0.8505 | 3.01 | 1.42 | 1.09 | 5.00 | 5.90 | 239,722.70 | -30.82 | -13.63 | -45.79 | -19.51 | 14.99 | 29.56 | -28.30 | -11.58 | 0.785 | -28.85 | 0.1375 | -- | -0.0685 | 13.98 | -95.85 | -- | 7.81 | -- |
| Icecure Medical Ltd | 2.98m | -15.29m | 39.31m | 64.00 | -- | 4.22 | -- | 13.21 | -0.2586 | -0.2586 | 0.0501 | 0.1349 | 0.196 | 0.8235 | 24.39 | 46,484.38 | -100.74 | -61.14 | -155.92 | -77.11 | 35.06 | 50.17 | -513.95 | -343.95 | 1.90 | -- | 0.00 | -- | 1.92 | 15.35 | -4.55 | -- | -6.51 | -- |
| Cytosorbents Corp | 34.35m | -10.59m | 40.28m | 149.00 | -- | 4.47 | -- | 1.17 | -0.19 | -0.19 | 0.56 | 0.1436 | 0.7344 | 2.18 | 4.89 | 230,553.30 | -22.63 | -34.58 | -28.22 | -41.80 | 77.02 | 70.00 | -30.81 | -62.08 | 1.71 | -- | 0.6176 | -- | 14.51 | 7.37 | 29.16 | -- | -15.13 | -- |
| Precipio Inc | 22.80m | -1.25m | 40.98m | 54.00 | -- | 2.97 | 169.34 | 1.80 | -0.835 | -0.835 | 14.63 | 7.88 | 1.20 | 18.26 | 15.31 | 422,222.20 | -6.58 | -38.01 | -8.60 | -46.98 | 44.82 | 33.80 | -5.50 | -71.34 | 1.10 | -24.19 | 0.074 | -- | 21.95 | 42.74 | 26.70 | -- | 32.31 | -- |
| Neuroone Medical Technologies Corp | 12.10m | -3.61m | 41.01m | 18.00 | -- | 5.75 | -- | 3.39 | -0.0784 | -0.0784 | 0.3012 | 0.1414 | 1.50 | 1.63 | 16.79 | 672,094.40 | -44.63 | -113.64 | -61.95 | -152.08 | 67.30 | 60.94 | -29.80 | -223.44 | 3.47 | -- | 0.1519 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
Data as of Feb 13 2026. Currency figures normalised to TELA Bio Inc's reporting currency: US Dollar USD
47.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nantahala Capital Management LLCas of 31 Dec 2025 | 5.11m | 11.48% |
| North Run Capital LPas of 31 Mar 2025 | 3.68m | 8.27% |
| SilverArc Capital Management LLCas of 31 Dec 2025 | 2.65m | 5.95% |
| Stonepine Capital Management LLCas of 31 Dec 2025 | 2.35m | 5.28% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.61m | 3.63% |
| UBS Securities LLCas of 31 Dec 2025 | 1.50m | 3.37% |
| DAFNA Capital Management LLCas of 30 Sep 2025 | 1.44m | 3.24% |
| Perkins Capital Management, Inc.as of 31 Dec 2025 | 1.40m | 3.14% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 2025 | 750.00k | 1.68% |
| Pentwater Capital Management LPas of 30 Sep 2025 | 724.86k | 1.63% |
More ▼
Data from 30 Sep 2025 - 05 Jan 2026Source: FactSet Research Systems Inc.
